Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans
暂无分享,去创建一个
G. Kokai | A. Grüters | M. Wlodarski | C. Niemeyer | Wei Chen | S. McKee | M. Erlacher | A. Brady | D. Morrogh | I. del Valle | J. Achermann | N. Khajavi | P. Kühnen | A. Procter | D. Moulding | H. Stachelscheid | G. Anderson | J. Wales | B. Strahm | P. Ghirri | M. Digweed | M. Didi | P. Dimitri | O. Blankenstein | J. Suntharalingham | Federica Buonocore | D. Knöbl | Peter Kühnen
[1] Deborah Nickerson,et al. Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L. , 2016, American journal of human genetics.
[2] H. Okano,et al. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7 , 2016, Nature Genetics.
[3] Lin Wu,et al. miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9 , 2015, Oncology letters.
[4] F. Baş,et al. Rare Causes of Primary Adrenal Insufficiency: Genetic and Clinical Characterization of a Large Nationwide Cohort , 2015, The Journal of clinical endocrinology and metabolism.
[5] A. Duncan,et al. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease , 2015, Best practice & research. Clinical endocrinology & metabolism.
[6] Ya-Li Yao,et al. Loading of PAX3 to Mitotic Chromosomes Is Mediated by Arginine Methylation and Associated with Waardenburg Syndrome* , 2015, The Journal of Biological Chemistry.
[7] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[8] Ting Gong,et al. Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer. , 2014, Biochemical and biophysical research communications.
[9] H. Honda,et al. −7/7q− syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity , 2014, Oncogene.
[10] Benjamin S. Freedman,et al. Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. , 2014, Journal of the American Society of Nephrology : JASN.
[11] P. Koopman,et al. Building the mammalian testis: origins, differentiation, and assembly of the component cell populations , 2013, Genes & development.
[12] T. Suda,et al. Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7. , 2013, Cancer cell.
[13] G. McFadden,et al. Evolution and divergence of the mammalian SAMD9/SAMD9L gene family , 2013, BMC Evolutionary Biology.
[14] J. Uitto,et al. Mouse Samd9l is not a functional paralogue of the human SAMD9, the gene mutated in normophosphataemic familial tumoral calcinosis , 2012, Experimental dermatology.
[15] S. Nelson,et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGE Syndrome , 2012, Nature Genetics.
[16] J. Scheys,et al. Evidence of adrenal failure in aging Dax1-deficient mice. , 2011, Endocrinology.
[17] C. Niemeyer,et al. Advances in the prognostication and management of advanced MDS in children , 2011, British journal of haematology.
[18] J. Uitto,et al. The Samd9L gene: transcriptional regulation and tissue-specific expression in mouse development. , 2011, The Journal of investigative dermatology.
[19] R. Jaffe,et al. Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit. , 2011, Endocrine reviews.
[20] O. Sarig,et al. Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis. , 2011, The Journal of investigative dermatology.
[21] Bernhard M. Schuldt,et al. A bioinformatic assay for pluripotency in human cells , 2011, Nature Methods.
[22] S. Kulkarni,et al. Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features suggestive of dyskeratosis congenita and IMAGe association , 2010, Pediatric blood & cancer.
[23] Y. Olshanskaya,et al. Myelodysplastic syndrome with monosomy 7 in a patient with XY gonadal dysgenesis (incomplete testicular feminization). , 2009, Cancer genetics and cytogenetics.
[24] T. Inaba,et al. Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome. , 2009, Biochemical and biophysical research communications.
[25] Mark George Thomas,et al. Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein. , 2008, The Journal of investigative dermatology.
[26] M. Dattani,et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. , 2007, The Journal of clinical endocrinology and metabolism.
[27] R. Y. Wei,et al. Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse , 2007, BMC Genomics.
[28] D. Geiger,et al. A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. , 2006, American journal of human genetics.
[29] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[30] E. Lalli,et al. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. , 2003, Molecular endocrinology.
[31] S. Bornstein,et al. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[32] S. Camper,et al. Role of Ahch in gonadal development and gametogenesis , 1998, Nature Genetics.
[33] W. Kutteh,et al. MONOSOMY 7 SYNDROME ASSOCIATED WITH CONGENITAL ADRENAL HYPOPLASIA AND MALE PSEUDOHERMAPHRODITISM , 1996, Obstetrics and gynecology.